Learn More
Triple-negative (TN) breast cancers were defined as those which tested negative for estrogen receptor (ER), progesterone receptor (PR), and HER2. TN breast cancers account for 12%– 26% of all types of breast cancers [1–5]. TN tumors were aggressive and were usually diagnosed at a later stage [5]. About 85% of TN phenotypic breast cancers are deemed to be(More)
The lymph node status is regarded as one of the most important prognostic factors for the overall and disease-free survival of patients with breast cancer. While morphological features and contrast enhancement kinetics of breast cancer shown on dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) have been correlated with tumor histological type,(More)
The tumor response of inflammatory breast cancer (IBC) after neoadjuvant chemotherapy (NAC) evaluated by magnetic resonance imaging (MRI) has been published in Annals of Surgical Oncology. 1 We have subsequently recently noticed a separate category of non-IBC with skin involvement. Non-IBC with skin involvement is different from IBC. The clinical course of(More)
  • 1